77 related articles for article (PubMed ID: 17822326)
1. Prognostic factors in stage-i (T1N0) breast carcinoma patients: who needs adjuvant systemic treatment?
Yildirim E; Berberoglu U
Neoplasma; 2007; 54(4):353-8. PubMed ID: 17822326
[TBL] [Abstract][Full Text] [Related]
2. Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified?
Yildirim E; Berberoglu U
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1024-9. PubMed ID: 17398017
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence in breast carcinoma patients with T(1-2) and 1-3 positive nodes: indications for radiotherapy.
Yildirim E; Berberoglu U
Eur J Surg Oncol; 2007 Feb; 33(1):28-32. PubMed ID: 17123771
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
5. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
Shen J; Hunt KK; Mirza NQ; Buchholz TA; Babiera GV; Kuerer HM; Bedrosian I; Ross MI; Ames FC; Feig BW; Singletary SE; Cristofanilli M; Meric-Bernstam F
Cancer; 2005 Aug; 104(3):479-90. PubMed ID: 15968686
[TBL] [Abstract][Full Text] [Related]
6. Locoregional recurrence in breast carcinoma patients.
Yildirim E
Eur J Surg Oncol; 2009 Mar; 35(3):258-63. PubMed ID: 18644692
[TBL] [Abstract][Full Text] [Related]
7. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
8. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
[TBL] [Abstract][Full Text] [Related]
10. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
11. The prognostic importance of triple negative breast carcinoma.
Mersin H; Yildirim E; Berberoglu U; Gülben K
Breast; 2008 Aug; 17(4):341-6. PubMed ID: 18450442
[TBL] [Abstract][Full Text] [Related]
12. Influence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer.
Truin W; Voogd AC; Vreugdenhil G; van der Sangen MJ; van Beek MW; Roumen RM
Breast; 2011 Dec; 20(6):505-9. PubMed ID: 21665471
[TBL] [Abstract][Full Text] [Related]
13. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer.
Kawano A; Shimizu C; Hashimoto K; Kinoshita T; Tsuda H; Fujii H; Fujiwara Y
Breast Cancer; 2013 Apr; 20(2):145-51. PubMed ID: 22139727
[TBL] [Abstract][Full Text] [Related]
15. Triple negative phenotype and N-ratio are important for prognosis in patients with stage IIIB non-inflammatory breast carcinoma.
Mersin H; Yildirim E; Berberoglu U; Gulben K
J Surg Oncol; 2009 Dec; 100(8):681-7. PubMed ID: 19798691
[TBL] [Abstract][Full Text] [Related]
16. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
[TBL] [Abstract][Full Text] [Related]
17. Distant metastasis after radical treatment of breast cancer: risk factors and their prognostic relevance in 378 consecutive patients.
Daskalova I; Popovska S; Betova T; Velkova A; Ivanova N; Baitchev G; Delijski T
J BUON; 2009; 14(2):229-33. PubMed ID: 19650171
[TBL] [Abstract][Full Text] [Related]
18. Body mass index influences palpability but not stage of breast cancer at diagnosis.
Chagpar AB; McMasters KM; Saul J; Nurko J; Martin RC; Scoggins CR; Edwards MJ
Am Surg; 2007 Jun; 73(6):555-60; discussion 560. PubMed ID: 17658091
[TBL] [Abstract][Full Text] [Related]
19. Predicting distant dissemination in patients with early breast cancer.
Arriagada R; Rutqvist LE; Johansson H; Kramar A; Rotstein S
Acta Oncol; 2008; 47(6):1113-21. PubMed ID: 18607866
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I-III of operable patients.
Gao D; Du J; Cong L; Liu Q
Jpn J Clin Oncol; 2009 Feb; 39(2):97-104. PubMed ID: 19052036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]